Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”

---

In the article titled “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway” [1], the protein labels in Figures 6(h) and 6(i) were reversed and should be corrected as follows:

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

Figure 6 

NLRP3 inhibitor MCC950 eliminated the protective effect of H-For on acute colitis in mice. (a) The experimental protocol with For and MCC950 in an acute colitis model. (b) Body weights of mice and (c) disease activity index (DAI) during the disease process. (d) Morphological changes in the mouse colons, (e) variations of colon length of mice, (f) representative HE staining, and (g) histological scores of colonic tissue. (h) Protein levels of claudin-1, occludin, and ZO-1 and (i) NLRP3, ASC, and IL-1β were analyzed by western blotting. , , .